The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bladder-sparing treatment for muscle-invasive bladder carcinoma: A single-center, single-arm clinical study of sequential neoadjuvant chemotherapy followed by tislelizumab neoadjuvant immunotherapy.
 
Yu Zeng
No Relationships to Disclose
 
Changqi Li
No Relationships to Disclose
 
Chengcheng Lv
No Relationships to Disclose
 
Cheng Fu
No Relationships to Disclose
 
Ang Chen
No Relationships to Disclose
 
Shui Fu
No Relationships to Disclose
 
Huan Bi
No Relationships to Disclose
 
Guangyi Shan
No Relationships to Disclose
 
Yiding Wang
No Relationships to Disclose
 
Zhe Wang
No Relationships to Disclose
 
Qiang Liu
No Relationships to Disclose
 
Bo Shao
No Relationships to Disclose